MGNet: Defining a Treatment-Responsive Biomarker for Corticosteroid Therapy in Myasthenia Gravis
14 de nov. de 2023 ·
1m 42s
Descarga y escucha en cualquier lugar
Descarga tus episodios favoritos y disfrútalos, ¡dondequiera que estés! Regístrate o inicia sesión ahora para acceder a la escucha sin conexión.
Descripción
New research from the Myasthenia Gravis Rare Disease Network (MGNet). This summary is based on a paper published in the journal PLOS One on October 10, 2023, titled "Serum metabolomics...
mostra más
New research from the Myasthenia Gravis Rare Disease Network (MGNet). This summary is based on a paper published in the journal PLOS One on October 10, 2023, titled "Serum metabolomics of treatment response in myasthenia gravis."
Read the paper here: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0287654
Learn more about MGNet: https://mgnet.rarediseasesnetwork.org
mostra menos
Read the paper here: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0287654
Learn more about MGNet: https://mgnet.rarediseasesnetwork.org
Información
| Autor | RDCRN |
| Organización | RDCRN |
| Página web | - |
| Etiquetas |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
Comentarios